Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001291520-16-000002
Filing Date
2016-03-11
Accepted
2016-03-10 17:32:40
Documents
1
Effectiveness Date
2016-03-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12164
  Complete submission text file 0001291520-16-000002.txt   13377
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 713-842-1249
PLX PHARMA INC. (Filer) CIK: 0001291520 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-259059 | Film No.: 161498753
SIC: 2834 Pharmaceutical Preparations